Patient Group Training on Marketing Authorization and HTA

A pharmaceutical company developing a new therapy for a rare neuromuscular disease recognized that patient organizations wanted to play a more active role in upcoming access discussions, but often lacked the knowledge and confidence to engage in marketing authorization and HTA processes. To support meaningful involvement, there was a need for a training approach that translated complex regulatory and market access topics into clear, relevant, and practical guidance for patient representatives.

To design and deliver a comprehensive yet accessible HTA training program for European patient organization representatives, enabling them to better understand marketing authorization and market access processes and prepare for meaningful involvement in upcoming country-specific HTA discussions, in full compliance with applicable requirements.

admedicum translated complex regulatory and HTA concepts into a practical, patient-friendly training experience that empowered patient organizations to engage more confidently and effectively. By combining subject-matter expertise with strong patient engagement know-how, admedicum helped build the capabilities needed for more meaningful patient involvement in future marketing authorization and market access processes.